← Devices & Neurotechnology
Details checkedClinical trial listing onlyCheckedregistry
Caffeine VEMP Screening Study
Also known as: Caffeine, Caffeine VEMP study
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Diagnostic
Modality
Diagnostic
Stage
Phase 4
Status
Unknown
Target Gene
—
Route / Mode
Oral
Confidence
70%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
Brazil
Population
adult, healthy-volunteer, diagnostic-study
Trial IDs
1
Mechanism
Single-dose caffeine challenge study measuring cervical vestibular evoked myogenic potentials in healthy subjects to assess test variability rather than to treat hearing loss.
Indications
Notes
The registry describes a screening/diagnostic physiology study in healthy subjects, not a therapeutic hearing-loss drug program. HearScape keeps it in the device/diagnostic silo with status unknown because the registry status is Unknown and the estimated completion date is historical.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...
IDs: NCT01693809
Key Events
Clinical Trials (1)
Data Checks
institution-led-studyregistry-verified-studycurrent-status-unknown-in-registrydiagnostic-study-not-productwas-therapeutic-misclassificationnot-commercial-pipeline-program
Related Programs
GeoAxon Kuduwave Pro
Company: GeoAxon · Diagnostic · Marketed
PATH MEDICAL SENTIERO ADVANCED
Company: PATH MEDICAL · Diagnostic · Marketed
Tympa Platform Ear and Hearing Health System
Company: TympaHealth · Diagnostic · Marketed
Mimi Hearing Test App
Company: Mimi Hearing Technologies · Diagnostic · Marketed
GSI Audera Pro
Company: Grason-Stadler · Diagnostic · Marketed
Natus ALGO 7i Newborn Hearing Screener
Company: Natus · Diagnostic · Marketed